Method and compositions for inhibiting cell proliferative disorders
US7217737B2 · kind B2 · utility
3Cited by
7References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 25, 2003 |
| Grant date | May 15, 2007 |
| Priority date | — |
| Expiry date | Feb 23, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C327/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns compounds and their use to inhibit the activity of a receptor tyrosine kinase. The invention is preferably used to treat cell proliferative disorders such as cancers characterized by over-activity or inappropriate activity HER2 or EGFR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.